Updated versions and new vaccines for COVID-19, influenza and respiratory syncytial virus will be rolled out this fall.are available for people age 60 and older. There are two vaccines available, one made by GSK and another from Pfizer. The CDC said healthcare providers should offer a dose of the vaccine “based on shared clinical decision-making between the healthcare provider and the patient,” language that falls short of a full recommendation that everyone in that age group get the vaccine.
Data suggest that both types of RSV vaccines are more than 80% efficacious in preventing RSV-associated lower respiratory tract disease, the CDC said. However, of nearly 40,000 participants in a clinical trial who received either vaccine, six developed inflammatory neurologic events within six weeks of the vaccination, “but it was unclear whether these events were related to [the] RSV vaccination,” the CDC said.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: MedicineNet - 🏆 575. / 51 Read more »